0N6A vs 4TO: Side-by-Side Comparison
Compare TME PHARM.CONF.IPO EO 1- (0N6A) and MAINZ BIOMED B.V. EO 1 (4TO) side by side: market cap EUR 5.91M vs EUR 4.55M. Financials, growth and model signals on Bullrun.
| Metric | 0N6A | 4TO |
|---|---|---|
| Company | TME PHARM.CONF.IPO EO 1- | MAINZ BIOMED B.V. EO 1 |
| Country / Exchange | Germany · F | Germany · F |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Diagnostics & Research |
| Market cap | EUR 5.91M | EUR 4.55M |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (latest FY) | EUR 0 | EUR 537.08K |
| Revenue growth YoY | — | -39.9% |
| Net income | EUR -5.72M | EUR -16.21M |
| Gross margin | — | 72.6% |
| Diluted EPS | — | -2.70 |